Halsted Pharma Private Limited, a active private limited company, was established on 02 September 2022 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290TG2022PTC166288. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹24.76 Cr.
It upholds a compliant status. Employing 85 professional, Its leadership includes Nagesh Kumar Middey (Director), Raghuveer Adusumilli (Director), Harsh Kumar Saxena (Whole-Time Director). Past directors included Nagesh Kumar Middey, Raghuveer Adusumilli, Venkata Ramaiah Jagarlamudi. It holds ₹8.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ground Floor, Plot No.25-Hig Phase Xv, Kphb Colony, Kukatpally, Hyderabad, Telangana, 500072.
U24290TG2022PTC166288
166288
02 September 2022
₹25.00 Cr
₹24.76 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Halsted Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagesh Kumar Middey | Director | 09 Oct 2023 | Current |
| Raghuveer Adusumilli | Director | 28 Sep 2022 | Current |
| Harsh Kumar Saxena | Whole-Time Director | 17 May 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 12 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 12 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 12 Dec 2023 | Past |
| Pramod Abcsdd | Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 17 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 17 May 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Halsted Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Halsted Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2023 | Hdfc Bank Limited | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
Halsted Pharma has a workforce of 85 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Halsted Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Halsted Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Halsted Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Halsted Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Akshay Mohitkumar Shah was appointed as a Company Secretary was appointed as a Company Secretary on 15 Feb 2024 & has been associated with this company since 1 year 10 months . was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 8.00 Cr with Charge ID 100838219 was registered on 07 Dec 2023. was completed.
Progress on Nagesh Kumar Middey was appointed as a Director was appointed as a Director on 09 Oct 2023 & has been associated with this company since 2 years 2 months . was documented.
Harsh Kumar Saxena was appointed as a Whole-time director was appointed as a Whole-time director on 17 May 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The CIN of Halsted Pharma Private Limited is U24290TG2022PTC166288.
Halsted Pharma Private Limited is headquartered at Ground Floor, Plot No.25-Hig Phase Xv, Kphb Colony, Kukatpally, Hyderabad, Telangana, 500072.
Halsted Pharma Private Limited was incorporated on 02 September 2022.
The current directors of Halsted Pharma Private Limited are
The primary industry of Halsted Pharma Private Limited is Pharma.
Halsted Pharma Private Limited is unlisted.
The authorized capital of Halsted Pharma Private Limited is ₹25.00 Cr, and the paid-up capital is ₹24.76 Cr.
The compliance status of Halsted Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX